Earnings Bridge Red Flags For Deal Teams
This conversation was generated using Cook'd AI's career assistant and reviewed by Fallon Han from our editorial team for accuracy.
I am a Master of Accounting student in Australia on a temporary graduate visa, and I am recruiting for transaction services at a Big 4 firm. I want a diagnostic interview that feels like a real finance case. Please drill me on a messy earnings bridge and make me call out red flags in quality of earnings, working capital, and normalization adjustments.
Great. I will run this like a transaction services interview. Assume you are reviewing a target company for a buyer and the seller has given you a messy earnings bridge from EBITDA to adjusted EBITDA. I will press you on the logic, not just the math.
Here is the setup: reported EBITDA is 18 million. Management adds back 2 million of one-time legal costs, 1.5 million of restructuring costs, and 3 million of founder salary that they say is above market. They also exclude a 1 million stock-based compensation charge and a 0.8 million software implementation expense. Working capital has increased sharply, but revenue is up only 4 percent while receivables are up 18 percent and inventory is up 25 percent.
First question: what is your initial view on the adjusted EBITDA bridge, and which three items would you challenge immediately?
My initial view is that the bridge looks aggressive. I would challenge the founder salary add-back first because that may be a real ongoing cost if the company needs that role. I would also challenge the stock-based compensation exclusion because although it is non-cash, it is still a recurring compensation expense and reflects true operating cost. I would question the software implementation expense too, because if it supports normal operations it may not be truly one-time.
I would be less concerned about the legal and restructuring costs at first, but I would still want to see whether they are genuinely non-recurring and whether the restructuring is already completed. Overall, I would suspect management is trying to inflate adjusted EBITDA by removing costs that should remain in the business.
Good instinct. You identified the right pressure points. Now go deeper.
If you were presenting this to the deal team, how would you separate truly non-recurring adjustments from items that are better viewed as recurring run-rate costs? Give me your framework, then apply it to the founder salary, stock-based compensation, and software implementation expense.
My framework would be to ask three questions for each adjustment: is it truly unusual, is it non-recurring, and would a buyer still incur it after acquisition?
For the founder salary, I would test whether the founder is exiting or reducing involvement. If the business still needs a commercial or technical leader, then some replacement cost should be included in the run-rate, so the full add-back is not justified.
For stock-based compensation, I would treat it as non-cash but not automatically non-recurring. If the company uses equity compensation as part of its normal remuneration strategy, then I would view it as a recurring cost that should be considered in quality of earnings.
For the software implementation expense, I would check whether it was tied to a genuine system transition. If it is part of a broader digitization project that will continue, then it may not be a one-off. If it relates to a new ERP already completed, then maybe a partial add-back is reasonable. I would ask for supporting invoices, timelines, and management memos for each item.
That is a strong answer. Now let us move to working capital.
Revenue is up only 4 percent, but receivables are up 18 percent and inventory is up 25 percent. What does that tell you about the business, and what red flags would you raise in a quality of earnings review? I want at least four concerns, including one tied to cash conversion.
That pattern suggests the business is consuming more working capital to support sales, which could mean weaker collections, inventory build-up, or less disciplined operations.
My red flags would be:
1. Receivables rising much faster than revenue, which may indicate slower collections, more lenient credit terms, or revenue quality issues such as aggressive cut-off.
2. Inventory increasing faster than revenue, which may signal overstocking, demand softness, obsolete stock, or poor forecasting.
3. Cash conversion deterioration, because higher working capital means less cash is being generated from profits, so EBITDA may overstate true cash earnings.
4. Possible channel stuffing or end-of-period sales pressure if revenue recognition looks too strong compared with cash collection.
I would also ask whether there is seasonality, because if this is not a seasonal peak, the movement is more concerning. I would compare month-end balances, aging reports, and days sales outstanding and days inventory outstanding against prior periods and budget.
Excellent. You are thinking like a transaction services analyst.
Last part: suppose management tells you adjusted EBITDA is 24.7 million, but after your review you conclude only 21.0 million is defensible. What does that mean for the deal, and how would you communicate the key takeaway in one sentence to a partner?
It means the business is less profitable than management is presenting, so valuation, debt capacity, and potentially purchase price may need to come down. It also suggests the business may have weaker underlying earnings quality and more working capital strain than first shown.
To a partner, I would say: management is presenting an inflated earnings bridge, and once we strip out questionable add-backs and account for working capital pressure, defensible run-rate EBITDA is materially lower, which reduces value and increases execution risk.